Zdrowie i gospodarka · 4.04.2001
Draft “Guidance for Industry: Reports on the Status of Postmarketing Studies-Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997;” Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Guidance for Industry: Reports on the Status of Postmarketing Studies--Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997." This draft guidance provides recommendations on procedures, content, and format for submitting a postmarketing study status report for an approved human drug or licensed biological product; timeframes for FDA's review of postmarketing studies; and information about postmarketing studies that will be available to the public. The draft guidance is intended to assist applicants in meeting the requirements of section 130 of the Food and Drug Administration Modernization Act of 1997.